Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Conflict Of Interest Screening Could Get Streamlined As Patient Involvement Increases

Executive Summary

Agency is considering creating a pool of pre-screened patient representatives that would make it easier to place them in FDA-sponsored formal meetings and advisory committees.

Advertisement

Related Content

US FDA May Change Advisory Committee Planning, Member Screening
Califf Lowering FDA Drawbridge To Work With External Expertise
Califf Lowering FDA Drawbridge To Work With External Expertise
Califf Lowering FDA Drawbridge To Work With External Expertise
Conflict Of Interest Reform: With FDA Undecided, Consumer Groups Give Their Pitch
PDUFA Word Association: Consumer Advocates Complain About Lack Of "Safety" In Commitment Letter

Topics

Advertisement
UsernamePublicRestriction

Register

PS054916

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel